Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2234471
Max Phase: Preclinical
Molecular Formula: C56H46O6
Molecular Weight: 814.98
Molecule Type: Small molecule
Associated Items:
ID: ALA2234471
Max Phase: Preclinical
Molecular Formula: C56H46O6
Molecular Weight: 814.98
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1CC(c2ccccc2)CC2=C1C(c1cccc(C3C4=C(CC(c5ccccc5)CC4=O)OC4=C3C(=O)CC(c3ccccc3)C4)c1)C1=C(CC(c3ccccc3)CC1=O)O2
Standard InChI: InChI=1S/C56H46O6/c57-43-25-39(33-14-5-1-6-15-33)29-47-53(43)51(54-44(58)26-40(30-48(54)61-47)34-16-7-2-8-17-34)37-22-13-23-38(24-37)52-55-45(59)27-41(35-18-9-3-10-19-35)31-49(55)62-50-32-42(28-46(60)56(50)52)36-20-11-4-12-21-36/h1-24,39-42,51-52H,25-32H2
Standard InChI Key: VWGQOFKAKODZTG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 814.98 | Molecular Weight (Monoisotopic): 814.3294 | AlogP: 11.52 | #Rotatable Bonds: 6 |
Polar Surface Area: 86.74 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 9.16 | CX LogD: 9.16 |
Aromatic Rings: 5 | Heavy Atoms: 62 | QED Weighted: 0.17 | Np Likeness Score: -0.08 |
1. Kaya M, Basar E, Colak F. (2011) Synthesis and antimicrobial activity of some bisoctahydroxanthene-1,8-dione derivatives, 20 (8): [10.1007/s00044-010-9459-2] |
Source(1):